Facebook
X
LinkedIn
ForwardDate & Time of Session - 9/25/26 - from 12-1 PM
Location:Todd234 - Tuesdays & MN263 - Fridays
Overview
Childhood obesity is among the most prevalent and complex chronic disease states affecting the pediatric population. This presentation will review guideline-directed management of pediatric obesity, the role of glucagon-like peptide-1 receptor agonists in pediatric weight management, obesogenic medications that warrant close monitoring, and dosing considerations for high-risk medications in children with obesity.
Objectives
Upon completion of this activity, participants will be able to:
1. Describe childhood obesity epidemiology nationally and in Kentucky
2. Summarize guideline-directed management of pediatric obesity
3. Evaluate evidence for glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in pediatric weight management
4. Apply dosing principles for medications in morbidly obese pediatric patients
Target Audience:
The audience includes pharmacy management, pharmacists, pharmacy residents, and pharmacy students.
Special Services
If you require special assistance to attend this event, please call Jacob Brooks at (606) 304-7493 or [email protected].
An Equal Opportunity University
Speaker
Whitney Seals, PharmD, MSHA
PGY2 Pediatrics Pharmacy Resident
UK College of Pharmacy – Lexington, Kentucky
- 1.00 ACPE
In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
This knowledge-based activity will award 1.00 contact hour(s) (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers. Course JA-UAN Number: JA0000312-0000-26-073-L01-P
- 1.00 ParticipationUK Healthcare CECentral certifies this activity for 1.00 hour(s) of participation.